November 15, 2024

Biofidelity launches Aspyre® Lung Reagents, now enabling integrated tissue and liquid biopsy analysis

Biofidelity: Fast, simple, decentralized testing from tissue and blood using standard PCR instruments New data to be presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA and RNA CAMBRIDGE, England and RESEARCH TRIANGLE PARK,...

recent articles

WED, DEC 27, 2023 12:00 CET - The Provincial Health Authority of Catania in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in the anatomic pathology laboratory of Gravina Hospital. The collaboration...

Gestalt: This award is another validation of our contributions to supporting better healthcare through technology. SPOKANE, Wash., Dec. 21, 2023 /PRNewswire/ -- Gestalt has been named the Most Innovative Company, 2023 by LaunchPad Inland...

Epredia and Aiforia Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program WINSTON-SALEM, N.C.--(BUSINESS WIRE)--PHC Group, a global healthcare company and leader in diagnostics and life sciences, will expand its...

South Korean biotech company GC Cell Corp. said Thursday that it signed a joint research and supply agreement with medical artificial intelligence (AI) company Lunit Inc. for new drug candidate AB-201. Under the agreement, GC Cell will conduct...

Owkin to collaborate with MSD to develop and commercialize AI-powered digital pathology Microsatellite Instability High (MSI-H) diagnostics for four types of cancer. The aim is to pre-screen patients for the MSI-H biomarker, which is found...

Driving Quality and Efficiency in Digital Pathology Workflows with AI-Enabled Tumor Assessment Boston, MA – December 14, 2023 – PathAI, a global leader in AI-powered pathology, today announced TumorDetect on AISightTM, PathAI’s...

OR

platinum partners

gold partners

Silver Partners

Media Partners